Decreased O-GlcNAcylation of the key proteins in kinase and redox signalling pathways is a novel mechanism of the beneficial effect of α-lipoic acid in diabetic liver

British Journal of Nutrition

Volumn 110, Issue 3, 2013, Pages 401-412

  Dinić, Svetlana ^a   Arambašić, Jelena ^a   Mihailović, Mirjana ^a   Uskoković, Aleksandra ^a   Grdović, Nevena ^a   Marković, Jelena ^a   Karadžić, Borivoje ^b   Poznanović, Goran ^a   Vidaković, Melita ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Lipoic acid; Diabetic liver; O GlcNAcylation; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CCAAT ENHANCER BINDING PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N ACETYLGLUCOSAMINE; O LINKED N ACETYLGLUCOSAMINE; THIOCTIC ACID; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CAT GENE; CONTROLLED STUDY; CUZNSOD GENE; CYTOTOXICITY; DIABETES MELLITUS; DNA DAMAGE; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; LIVER; LIVER CELL DAMAGE; LIVER PROTECTION; MALE; MNSOD GENE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

AMINOACYLATION; ANIMALS; ANTIOXIDANTS; CATALASE; CCAAT-BINDING FACTOR; DIABETES MELLITUS, EXPERIMENTAL; DNA DAMAGE; GLUTATHIONE; GLUTATHIONE DISULFIDE; LIVER; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE; THIOCTIC ACID; TRANSAMINASES; TRANSCRIPTION, GENETIC;

EID: 84880770415     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512005429     Document Type: Article

References (67)

1. Maritim AC, Sanders RA & Watkins JB (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17, 24-38.
2. Kakkar R, Mantha SV, Radhi J, et al. (1998) Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci 94, 623-632.
3. Tolman KG, Fonseca V, Dalpiaz A, et al. (2007) Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 30, 734-743.
4. Rutter GA (2000) Diabetes: the importance of the liver. Curr Biol 10, R736-R738.
5. Evelson P, Susemihl C, Villarreal I, et al. (2005) Hepatic morphological changes and oxidative stress in chronic streptozotocin-diabetic rats. Ann Hepatol 4, 115-120.
6. Guven A, Yavuz O, Cam M, et al. (2006) Effects of melatonin on streptozotocin-induced diabetic liver injury in rats. Acta Histochem 108, 85-93.
7. Parker GJ, Lund KC, Taylor RP, et al. (2003) Insulin resistance of glycogen synthase mediated by O-linked N-acetylglucosamine. J Biol Chem 278, 10022-10027.
8. Yang X, Su K, Roos MD, et al. (2001) O-Linkage of Nacetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci USA 98, 6611-6616.
9. Gao Y, Miyazaki J & Hart GW (2003) The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. Arch Biochem Biophys 415, 155-163.
10. Juang YT, Solomou EE, Rellahan B, et al. (2002) Phosphorylation and O-linked glycosylation of Elf-1 leads to its translocation to the nucleus and binding to the promoter of the TCR zeta-chain. J Immunol 168, 2865-2871.
11. Zachara NE & Hart GW (2004) O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 1673, 13-28.
12. Karunakaran U & Jeoung NH (2010) O-GlcNAc modification: friend or foe in diabetic cardiovascular disease. Korean Diabetes J 34, 211-219.
13. Reber L, Vermeulen L, Haegeman G, et al. (2009) Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. PLoS One 4, e4393.
14. Piwien-Pilipuk G, MacDougald O & Schwartz J (2002) Dual regulation of phosphorylation and dephosphorylation of C/EBPbeta modulate its transcriptional activation and DNA binding in response to growth hormone. J Biol Chem 277, 44557-44565.
15. Dhakshinamoorthy S, Long DJ & Jaiswal AK (2000) Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr Top Cell Regul 36, 201-216.
16. Miao L & St Clair DK (2009) Regulation of superoxide dismutase genes: implications in diseases. Free Radic Biol Med 47, 344-356.
17. Nozik-Grayck E, Suliman HB & Piantadosi CA (2005) Extracellular superoxide dismutase. Int J Biochem Cell B 37, 2466-2471.
18. Moini H, Packer L & Saris NEL (2002) Antioxidant and prooxidant activities of a-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharm 182, 84-90.
19. Packer L, Kraemer K & Rimbach G (2001) Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17, 888-895.
20. Petersen Shay K, Moreau RF, Smith EJ, et al. (2009) Alphalipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 1790, 1149-1160.
21. Sadi G & Güray T (2009) Gene expressions of Mn-SOD and GPx-1 in streptozotocin-induced diabetes: effect of antioxidants. Mol Cell Biochem 327, 127-134.
22. Rossini AA, Like AA, Chick WL, et al. (1977) Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci USA 74, 2485-2489.
23. Maritim AC, Sanders RA & Watkins JB (2003) Effects of a-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 14, 288-294.
24. Johnson RN, Metcalf PA & Baker JR (1982) Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 127, 87-95.
25. Ohkawa H, Ohishi N & Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95, 351-358.
26. Ellman CL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82, 70-77.
27. Lowry OH, Rosebrough NL, Farr AL, et al. (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193, 265-275.
28. Misra HP & Fridovich I (1972) The role of superoxide anion in the autooxidation of epinephrine and simple assay for superoxide dismutase. J Biol Chem 247, 3170-3175.
29. Claiborne A (1984) Catalase activity. In Handbook of Methods for Oxygen Radical Research, pp. 283-284 [RA Greenwald, editor]. Boca Raton, FL: CRC Press, Inc.
30. Albrektsen T, Richter HE, Clausen JT, et al. (2001) Identification of a novel integral plasma membrane protein induced during adipocyte differentiation. Biochem J 359, 393-402.
31. Jackson SP & Tjian R (1989) Purification and analysis of RNA polymerase II transcription factors by using wheat germ agglutinin affinity chromatography. Proc Natl Acad Sci USA 86, 1781-1785.
32. Laemmli UK (1970) Cleavage of structural proteins during the assembly of heat of bacteriophage T4. Nature 227, 680-685.
33. Towbin H, Staehelin T & Gordon J (1979) Electrophoretic transfer of proteins from polyacrilamifostinede gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76, 4350-4354.
34. Ossipow V, Descombes P & Schibler U (1993) CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci USA 90, 8219-8223.
35. Packer L & Cadenas E (2011) Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling. J Clin Biochem Nutr 48, 26-32.
36. Hart GW, Housley MP & Slawson C (2007) Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446, 1017-1022.
37. Michael MD, Kulkarni RN, Postic C, et al. (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6, 87-97.
38. Mitra V & Metcalf J (2009) Metabolic functions of the liver. Anaesth Intens Care Med 10, 334-335.
39. Zafar M & Naqvi SNH (2010) Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: a comparative study. Int J Morphol 28, 135-142.
40. Godin DV, Wohaieh SA, Garnett ME, et al. (1988) Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem 84, 223-231.
41. Limaye PV, Raghuram N & Sivakami S (2003) Oxidative stress and gene expression of antioxidant enzymes in the renal cortex of streptozotocin-induced diabetic rats. Mol Cell Biochem 243, 147-152.
42. Sadi G, Ylmaz Ö & Güray T (2008) Effect of vitamin C and lipoic acid on streptozotocin-induced diabetes gene expression: mRNA and protein expressions of Cu-Zn SOD and catalase. Mol Cell Biochem 309, 109-116.
43. Cardinal JW, Margison GP, Mynett KJ, et al. (2001) Increased susceptibility to streptozotocin-induced beta cell apoptosis and delayed autoimmune diabetes in alkylpurine-DNA-Nglycosylase-deficient mice. Mol Cell Biol 21, 5605-5613.
44. Ö zcan S, Andrali SS & Cantrell JEL (2010) Modulation of transcription factor function by O-GlcNAc modification. Biochim Biophys Acta 1799, 353-364.
45. Cao C, Leng Y & Kufe D (2003) Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. J Biol Chem 278, 29667-29675.
46. Cao C, Leng Y, Liu X, et al. (2003) Catalase is regulated by ubiquitination and proteosomal degradation. Role of the c-Abl and Arg tyrosine kinases. Biochemistry 42, 10348-10353.
47. Liu X, Huang W, Li C, et al. (2006) Interaction between c-Abl and Arg tyrosine kinases and proteasome subunit PSMA7 regulates proteasome degradation. Mol Cell 22, 317-327.
48. Yamakura F & Kawasaki H (2010) Post-translational modifications of superoxide dismutase. Biochim Biophys Acta 1804, 318-325.
49. Rechsteiner M & Rogers SW (1996) PEST sequences and regulation by proteolysis. Trends Biochem Sci 21, 267-271.
50. Vermeulen L, De Wilde G, Van Damme P, et al. (2003) Transcriptional activation of the NF-kappaB p65 subunit by mitogen-and stress-activated protein kinase-1 (MSK1). EMBO J 22, 1313-1324.
51. Hu J, Roy SK, Shapiro PS, et al. (2001) ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. J Biol Chem 276, 287-297.
52. Sen KC & Packer L (1996) Antioxidant and redox regulation of gene transcription. FASEB J 10, 709-720.
53. King GL (2008) The role of inflammatory cytokines in diabetes and its complications. J Periodontol 79, 1527-1534.
54. Baker RG, Hayden MS & Ghosh S (2011) NF-kB, inflammation, and metabolic disease. Cell Metab 13, 11-22.
55. Rojo AI, Salinas M, Martin D, et al. (2004) Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J Neurosci 24, 7324-7334.
56. St Clair DK, Porntadavity S, Xu Y, et al. (2002) Transcription regulation of human manganese superoxide dismutase gene. Method Enzymol 349, 306-312.
57. Taniguchi M, Hashimoto M, Hori N, et al. (2005) CCAAT/enhancer binding protein-b (C/EBP-b), a pivotal regulator of the TATA-less promoter in the rat catalase gene. FEBS Lett 579, 5785-5790.
58. Seo SJ, Kim HT, Cho G, et al. (1996) Sp1 and C/EBP-related factor regulate the transcription of human Cu/Zn SOD gene. Gene 178, 177-185.
59. Seo SJ, Kang SS, Cho G, et al. (1997) C/EBP alpha and C/EBPbeta play similar roles in the transcription of the human Cu/Zn SOD gene. Gene 203, 11-15.
60. Kim YH, Yoo HY, Chang MS, et al. (1997) C/EBP alpha is a major activator for the transcription of rat Cu/Zn superoxide dismutase gene in liver cell. FEBS Lett 401, 267-270.
61. Qiu X, Aiken KJ, Chokas AL, et al. (2008) Distinct functions of CCAAT enhancer-binding protein isoforms in the regulation of manganese superoxide dismutase during interleukin-1beta stimulation. J Biol Chem 283, 25774-25785.
62. Yang WH, Park SY,NamHW, et al. (2008) NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc Natl Acad Sci USA 105, 17345-17350.
63. Bosch F, Sabater J & Valera A (1995) Insulin inhibits liver expression of the CCAAT/enhancer-binding protein beta. Diabetes 44, 267-271.
64. Arizmendi C, Liu S, Croniger C, et al. (1999) The transcription factor CCAAT-enhancer binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 274, 13033-13040.
65. Singh U & Jialal I (2008) Alpha-lipoic acid supplementation and diabetes. Nutr Rev 66, 646-657.
66. Ridruejo E, Castiglioni T & O Silva M (2011) Thioctic acid-induced acute cholestatic hepatitis. Ann Pharmacother 45, e43.
67. Wassmann S, Wassmann K & Nickenig G (2004) Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44, 381-386. the Republic of Serbia